BACKGROUND: Intraventricular haemorrhage (IVH) and periventricular leucomalacia (PVL) in premature infants presumably have many causes. It has been proposed that inflammatory processes in the fetomaternal unit play an important role in the pathogenesis of these lesions. OBJECTIVE: To study the correlation of postpartum serum interleukin 6 (IL6) concentration as a marker of inflammation and neonatal cerebral morbidity in preterm infants < 28 weeks of gestational age. METHODS: A total of 88 infants were grouped according to maximum serum IL6 levels within 12 hours post partum: group A (n = 50), < or = 100 pg/ml; group B (n = 38), > 100 pg/ml. Ultrasound studies and clinical assessment were performed routinely. RESULTS: IVH was noted significantly more often in group B (24/38; 63%) than in group A (19/50; 38%) (p = 0.02). In a multiple logistic regression model, raised serum IL6 independently predicted development of severe IVH (odds ratio 8.4; 95% confidence interval 2.85 to 24.9; p = 0.0001). CONCLUSIONS: Raised serum IL6 may serve as a marker for severe IVH in infants < 28 weeks of gestational age. Although cerebral morbidity in premature infants is determined by different variables, the identification of systemic inflammation can help to define the need for anti-inflammatory strategies to prevent cerebral morbidity.
BACKGROUND: Intraventricular haemorrhage (IVH) and periventricular leucomalacia (PVL) in premature infants presumably have many causes. It has been proposed that inflammatory processes in the fetomaternal unit play an important role in the pathogenesis of these lesions. OBJECTIVE: To study the correlation of postpartum serum interleukin 6 (IL6) concentration as a marker of inflammation and neonatal cerebral morbidity in preterm infants < 28 weeks of gestational age. METHODS: A total of 88 infants were grouped according to maximum serum IL6 levels within 12 hours post partum: group A (n = 50), < or = 100 pg/ml; group B (n = 38), > 100 pg/ml. Ultrasound studies and clinical assessment were performed routinely. RESULTS: IVH was noted significantly more often in group B (24/38; 63%) than in group A (19/50; 38%) (p = 0.02). In a multiple logistic regression model, raised serum IL6 independently predicted development of severe IVH (odds ratio 8.4; 95% confidence interval 2.85 to 24.9; p = 0.0001). CONCLUSIONS: Raised serum IL6 may serve as a marker for severe IVH in infants < 28 weeks of gestational age. Although cerebral morbidity in premature infants is determined by different variables, the identification of systemic inflammation can help to define the need for anti-inflammatory strategies to prevent cerebral morbidity.
Authors: S Eklind; C Mallard; A L Leverin; E Gilland; K Blomgren; I Mattsby-Baltzer; H Hagberg Journal: Eur J Neurosci Date: 2001-03 Impact factor: 3.386
Authors: P Toti; R N Laurini; M Stumpo; E Picciolini; T Todros; P Tanganelli; G Buonocore; R Bracci Journal: J Pediatr Date: 2001-01 Impact factor: 4.406
Authors: J K Davies; R H Shikes; C I Sze; K K Leslie; R S McDuffie; R Romero; R S Gibbs Journal: Am J Obstet Gynecol Date: 2000-11 Impact factor: 8.661
Authors: Maria Andrikopoulou; Ahmad Almalki; Azadeh Farzin; Christina N Cordeiro; Michael V Johnston; Irina Burd Journal: Int J Dev Neurosci Date: 2014-04-24 Impact factor: 2.457
Authors: Yoram Sorokin; Roberto Romero; Lisa Mele; Ronald J Wapner; Jay D Iams; Donald J Dudley; Catherine Y Spong; Alan M Peaceman; Kenneth J Leveno; Margaret Harper; Steve N Caritis; Menachem Miodovnik; Brian M Mercer; John M Thorp; Mary Jo O'Sullivan; Susan M Ramin; Marshall W Carpenter; Dwight J Rouse; Baha Sibai Journal: Am J Perinatol Date: 2010-03-01 Impact factor: 1.862
Authors: Vineet Bhandari; Catalin S Buhimschi; Christina S Han; Sarah Y Lee; Christian M Pettker; Katherine H Campbell; Antonette T Dulay; Emily A Oliver; Erika F Werner; Irina A Buhimschi Journal: J Matern Fetal Neonatal Med Date: 2010-10-12
Authors: Alan Leviton; Elizabeth N Allred; Olaf Dammann; Stephen Engelke; Raina N Fichorova; Deborah Hirtz; Karl C K Kuban; Laura R Ment; T Michael O'shea; Nigel Paneth; Bhavesh Shah; Michael D Schreiber Journal: J Child Neurol Date: 2012-10-30 Impact factor: 1.987